J. Muñoz‐Basagoiti

SARS-CoV-2 Cellular Infection and Therapeutic Opportunities: Lessons Learned from Ebola Virus

B. Clotet, J. Blanco, J. Carrillo, 2021, Membranes.

Identification of Plitidepsin as Potent Inhibitor of SARS-CoV-2-Induced Cytopathic Effect After a Drug Repurposing Screen

R. Paredes, B. Clotet, J. Segalés, 2020, Frontiers in Pharmacology.

Pre-clinical search of SARS-CoV-2 inhibitors and their combinations in approved drugs to tackle COVID-19 pandemic

R. Paredes, B. Clotet, J. Segalés, 2020, bioRxiv.

Safety and Immunogenicity of a Recombinant Protein RBD Fusion Heterodimer Vaccine against SARS-CoV-2: preliminary results of a phase 1-2a dose-escalating, randomized, double-blind clinical trial.

J. Blanco, B. Trinité, L. Leal, 2022, medRxiv.

HIV-1 trans-Infection Mediated by DCs: The Tip of the Iceberg of Cell-to-Cell Viral Transmission

B. Clotet, J. Blanco, C. Aguilar-Gurrieri, 2021, Pathogens.

Role of Siglecs in viral infections: A double-edged sword interaction

B. Clotet, J. Martinez-Picado, Patricia Resa-Infante, 2022, Molecular aspects of medicine.